Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two different preparations of tetanus toxin (
HTT
and WTT) were iodinated, and their binding to rat brain membranes characterized. Under optimal binding conditions (25 mM Tris-acetate, pH 6.0), both preparations bound to a large number of high affinity sites, thought to be gangliosides. Binding constants were identical. However, in a physiological buffer (Krebs-Ringer, pH 7.4) binding of the two toxin preparations showed a number of differences. Under these conditions we have previously shown that
HTT
binding is markedly reduced, and that there are two classes of sites, a small number of heat-,
sialidase
- and protease-sensitive high affinity sites, and a larger number of
sialidase
-sensitive, heat- and protease-resistant lower affinity sites, probably gangliosides (PIERCE et al. (1986) Biochem. J. 236, 845-852). Although WTT bound to these same two sites, it displayed a higher affinity for the protease-resistant site than did
HTT
. WTT also bound to free or immobilized trisialoganglioside with higher affinity than
HTT
, consistent with the view that the protease-resistant site represents binding to ganglioside. In contrast, both toxin preparations bound to the protease-sensitive site with similar affinities. These observations may explain the four to five-fold higher levels of WTT binding to brain membranes, and the fact that a smaller percentage of total WTT binding is protease sensitive. Despite their different ganglioside-binding properties, both toxin preparations showed comparable neurotoxic activities, and appeared identical on SDS gels.
...
PMID:Comparison of the binding characteristics of two different preparations of tetanus toxin to rat brain membranes. 271 11